P64

Q3 Medicine
T. Kunts , K. Karpukhina , E. Mikhailova , N. Varaksin , A. Autenshlyus
{"title":"P64","authors":"T. Kunts ,&nbsp;K. Karpukhina ,&nbsp;E. Mikhailova ,&nbsp;N. Varaksin ,&nbsp;A. Autenshlyus","doi":"10.1016/j.ejcsup.2015.08.053","DOIUrl":null,"url":null,"abstract":"<div><p>Growing tumor and its microenvironment are capable to produce a number of cytokines that alter the nature of the antitumor surveillance by host immune system.</p></div><div><h3>Objective</h3><p>Comparative evaluation of cytokine-producing function of the invasive ductal carcinoma and fibroadenoma of the breast in vitro.</p></div><div><h3>Materials and methods</h3><p>Similar biopsies (<em>V</em> <!-->=<!--> <!-->8<!--> <!-->mm<sup>3</sup>) of the breast tumors were obtained using a special device, cultivated in DMEM F-12 at 37<!--> <!-->°C for 72<!--> <!-->h. Concentrations of the following cytokines: IL-1<em>β</em>, IL-1Ra, TNF<em>α</em>, IL-2, IL-6, IL-8, IL-10, IL-17, IL-18, VEGF and IFN<em>γ</em> in the supernatant of the tumor were measured with enzyme-linked immunosorbent assay (ELISA).</p></div><div><h3>Results</h3><p>The investigation of cytokines level in the supernatant of malignant and benign breast tumors revealed significant differences only in concentrations of IL-10, IL-17, IL-18 and IFN<em>γ</em> which had a contrary tendency. For example, the concentration of IL-10 was lower at invasive ductal carcinoma in comparison with fibroadenomas. The concentrations of IL-17, IL-18 and IFN<em>γ</em> at invasive ductal carcinoma were significantly higher than those of breast fibroadenomas. IL-17 and IL-18 are known to be pro-oncogenic cytokines, and the higher the level, the higher the severity of tumor progression. Reduction in the IL-10 concentration might be explained by the already formed neoplasm, which depends on angiogenesis. In this case, IL-10 no longer exerts antiangiogenic action, which contributes to tumor progression. Reduction in the IL-10 concentration, which inhibits the production of IFN<em>γ</em> leads to an increase in the IFN<em>γ</em> level. In early stages of tumor development, IFN<em>γ</em> provides an antitumor effect and at the same time facilitates the selection of a more malignant clones but its pro-tumoral action predominates at advanced stages of tumorigenesis. Moreover, higher concentration of IFN<em>γ</em> is supposed to be associated with biological effects of IL-18, which is its immediate inductor. In addition, malignant tumor cells are capable to produce their own IL-18, which stimulates tumor progression and facilitates the migration of endothelial cells involved in angiogenesis, which leads to intensified invasion and metastasis.</p></div><div><h3>Conclusion</h3><p>Cytokine production in supernatants of invasive ductal carcinoma compared with fibroadenoma of the breast is characterized by increase in IL-17, IL-18 and IFN<em>γ</em> concentrations and decrease in IL-10 concentration. Findings suggest the ability of malignant tumor and its microenvironment to secrete the pro-oncogenic cytokines. Fibroadenoma is also able to produce cytokines due to fibroblasts, fibrocytes and some leukocytes in its content.</p></div>","PeriodicalId":11675,"journal":{"name":"Ejc Supplements","volume":"13 1","pages":"Page 30"},"PeriodicalIF":0.0000,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejcsup.2015.08.053","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejc Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359634915000543","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Growing tumor and its microenvironment are capable to produce a number of cytokines that alter the nature of the antitumor surveillance by host immune system.

Objective

Comparative evaluation of cytokine-producing function of the invasive ductal carcinoma and fibroadenoma of the breast in vitro.

Materials and methods

Similar biopsies (V = 8 mm3) of the breast tumors were obtained using a special device, cultivated in DMEM F-12 at 37 °C for 72 h. Concentrations of the following cytokines: IL-1β, IL-1Ra, TNFα, IL-2, IL-6, IL-8, IL-10, IL-17, IL-18, VEGF and IFNγ in the supernatant of the tumor were measured with enzyme-linked immunosorbent assay (ELISA).

Results

The investigation of cytokines level in the supernatant of malignant and benign breast tumors revealed significant differences only in concentrations of IL-10, IL-17, IL-18 and IFNγ which had a contrary tendency. For example, the concentration of IL-10 was lower at invasive ductal carcinoma in comparison with fibroadenomas. The concentrations of IL-17, IL-18 and IFNγ at invasive ductal carcinoma were significantly higher than those of breast fibroadenomas. IL-17 and IL-18 are known to be pro-oncogenic cytokines, and the higher the level, the higher the severity of tumor progression. Reduction in the IL-10 concentration might be explained by the already formed neoplasm, which depends on angiogenesis. In this case, IL-10 no longer exerts antiangiogenic action, which contributes to tumor progression. Reduction in the IL-10 concentration, which inhibits the production of IFNγ leads to an increase in the IFNγ level. In early stages of tumor development, IFNγ provides an antitumor effect and at the same time facilitates the selection of a more malignant clones but its pro-tumoral action predominates at advanced stages of tumorigenesis. Moreover, higher concentration of IFNγ is supposed to be associated with biological effects of IL-18, which is its immediate inductor. In addition, malignant tumor cells are capable to produce their own IL-18, which stimulates tumor progression and facilitates the migration of endothelial cells involved in angiogenesis, which leads to intensified invasion and metastasis.

Conclusion

Cytokine production in supernatants of invasive ductal carcinoma compared with fibroadenoma of the breast is characterized by increase in IL-17, IL-18 and IFNγ concentrations and decrease in IL-10 concentration. Findings suggest the ability of malignant tumor and its microenvironment to secrete the pro-oncogenic cytokines. Fibroadenoma is also able to produce cytokines due to fibroblasts, fibrocytes and some leukocytes in its content.

P64
生长中的肿瘤及其微环境能够产生大量细胞因子,从而改变宿主免疫系统抗肿瘤监测的性质。目的比较评价乳腺浸润性导管癌和纤维腺瘤体外细胞因子生成功能。材料与方法采用特殊装置取乳腺肿瘤组织切片(V = 8 mm3),在DMEM F-12培养液中37℃培养72 h,采用酶联免疫吸附法(ELISA)测定肿瘤上清液中IL-1β、IL-1Ra、TNFα、IL-2、IL-6、IL-8、IL-10、IL-17、IL-18、VEGF和IFNγ的浓度。结果对乳腺恶性肿瘤和良性肿瘤上清细胞因子水平的调查显示,只有IL-10、IL-17、IL-18和IFNγ的浓度有相反的趋势,而IL-10、IL-17、IL-18和IFNγ的浓度有显著差异。例如,浸润性导管癌的IL-10浓度低于纤维腺瘤。浸润性导管癌组织中IL-17、IL-18和IFNγ的浓度明显高于乳腺纤维腺瘤组织。IL-17和IL-18是已知的促癌细胞因子,其水平越高,肿瘤进展越严重。IL-10浓度的降低可能与已经形成的肿瘤有关,肿瘤依赖于血管生成。在这种情况下,IL-10不再发挥抗血管生成作用,这有助于肿瘤的进展。抑制IFNγ产生的IL-10浓度降低导致IFNγ水平升高。在肿瘤发展的早期阶段,IFNγ提供抗肿瘤作用,同时促进更恶性克隆的选择,但其促肿瘤作用在肿瘤发生的晚期阶段占主导地位。此外,较高浓度的IFNγ被认为与IL-18的生物学效应有关,IL-18是其直接诱导剂。此外,恶性肿瘤细胞自身能够产生IL-18, IL-18刺激肿瘤进展,促进参与血管生成的内皮细胞迁移,导致侵袭转移加剧。结论与乳腺纤维腺瘤相比,浸润性导管癌上清中细胞因子的产生具有IL-17、IL-18和ifn - γ浓度升高和IL-10浓度降低的特点。研究结果提示恶性肿瘤及其微环境具有分泌促癌细胞因子的能力。纤维腺瘤也能产生细胞因子,因为它含有成纤维细胞、纤维细胞和一些白细胞。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ejc Supplements
Ejc Supplements 医学-肿瘤学
自引率
0.00%
发文量
0
审稿时长
3.7 months
期刊介绍: EJC Supplements is an open access companion journal to the European Journal of Cancer. As an open access journal, all published articles are subject to an Article Publication Fee. Immediately upon publication, all articles in EJC Supplements are made openly available through the journal''s websites. EJC Supplements will consider for publication the proceedings of scientific symposia, commissioned thematic issues, and collections of invited articles on preclinical and basic cancer research, translational oncology, clinical oncology and cancer epidemiology and prevention. Authors considering the publication of a supplement in EJC Supplements are requested to contact the Editorial Office of the EJC to discuss their proposal with the Editor-in-Chief. EJC Supplements is an official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO) and the European Society of Mastology (EUSOMA).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信